Telomere dysfunction activates YAP1 to drive tissue inflammation
Deepavali Chakravarti1, Baoli Hu1,2,3, Xizeng Mao4
1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Abstract:
Germline telomere maintenance defects are associated with an increased incidence of inflammatory diseases in humans, yet whether and how telomere dysfunction causes inflammation are not known. Here, we show that telomere dysfunction drives pATM/c-ABL-mediated activation of the YAP1 transcription factor, up-regulating the major pro-inflammatory factor, pro-IL-18. The colonic microbiome stimulates cytosolic receptors activating caspase-1 which cleaves pro-IL-18 into mature IL-18, leading to recruitment of interferon (IFN)-γ-secreting T cells and intestinal inflammation. Correspondingly, patients with germline telomere maintenance defects exhibit DNA damage (γH2AX) signaling together with elevated YAP1 and IL-18 expression. In mice with telomere dysfunction, telomerase reactivation in the intestinal epithelium or pharmacological inhibition of ATM, YAP1, or caspase-1 as well as antibiotic treatment, dramatically reduces IL-18 and intestinal inflammation. Thus, telomere dysfunction-induced activation of the ATM-YAP1-pro-IL-18 pathway in epithelium is a key instigator of tissue inflammation.
Insights
Telomere dysfunction triggers inflammation by activating the ATM-YAP1-pro-IL-18 pathway. Inhibiting this pathway or using antibiotics reduces intestinal inflammation in mice.
Area of Science:
- Molecular Biology
- Immunology
- Genetics
Background:
- Germline telomere maintenance defects are linked to inflammatory diseases.
- The precise mechanisms by which telomere dysfunction causes inflammation remain unclear.
Purpose of the Study:
- To elucidate the molecular pathways linking telomere dysfunction to inflammation.
- To investigate the role of the ATM-YAP1-pro-IL-18 axis in telomere-related inflammation.
Main Methods:
- Investigated telomere dysfunction in human patients and mouse models.
- Utilized molecular biology techniques to analyze protein activation and gene expression.
- Employed pharmacological inhibitors and antibiotic treatments in mouse models.
Main Results:
- Telomere dysfunction activates the pATM/c-ABL-YAP1 pathway, upregulating pro-IL-18.
- The colonic microbiome activates caspase-1, maturing IL-18 and promoting IFN-γ T cell recruitment and intestinal inflammation.
- Patients with telomere defects show DNA damage, elevated YAP1, and IL-18.
- Therapeutic interventions (telomerase reactivation, ATM/YAP1/caspase-1 inhibition, antibiotics) reduced inflammation in mice.
Conclusions:
- Telomere dysfunction drives intestinal inflammation via the ATM-YAP1-pro-IL-18 pathway in the epithelium.
- This pathway represents a potential therapeutic target for inflammatory diseases associated with telomere defects.
Related Concept Videos
Telomeres and Telomerase
Telomeres and Telomerase
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
Replicative Cell Senescence


